ERBB2 and triple-negative breast carcinoma: As shown in Figure 4, all ABPs significantly correlating with the ability of the primary tumor to form distant metastases were preferentially expressed by HER2-positive and triple-negative breast cancer, even ARHGAP25 showing an inverse correlation with metastasis-free survival probability.